Online Trial Tracker - Larvol Sigma

efpeglenatide (HM11260C) / Hanmi, Sanofi

Welcome, Profile Billing Logout

1 Trials

Active Trials

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

efpeglenatide (HM11260C) / Hanmi

NCT06174779: A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus

Not yet recruiting

420

HM11260C, Placebo

Hanmi Pharmaceutical Company Limited

Obesity

12/25

07/26

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites